IFNG and neoplasm: While endogenous IFNγ signaling is clearly important for immune surveillance, high-dose administration of exogenous IFNγ strongly stimulates PD-L1 expression in the tumor microenvironment, and hampers therapy with agents that enforce ICB[41].